Viatris Inc (VTRS:NAS) Company Profile: Analytics, Extensive Financial Metrics, and Benchmark Against Averages and Top Companies Within its IndustryGlobeNewsWire • 7h
Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business DivestiturePRNewsWire • 07/03/24
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust InvestigationPRNewsWire • 07/02/24
Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/11/24
Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)Seeking Alpha • 06/06/24
Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferencePRNewsWire • 06/04/24
Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at ScalePRNewsWire • 05/21/24
Idorsia announces financial results for the first quarter 2024 – advancing the company with renewed vigorGlobeNewsWire • 05/21/24
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/09/24
Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance RangesPRNewsWire • 05/09/24